Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 23771854)

1.

Penetration of micafungin into the burn eschar in patients with severe burns.

Sasaki J, Yamanouchi S, Sato Y, Abe S, Shinozawa Y, Kishino S, Aikawa N, Hori S.

Eur J Drug Metab Pharmacokinet. 2014 Jun;39(2):93-7. doi: 10.1007/s13318-013-0146-9. Epub 2013 Jun 15.

PMID:
23771854
2.

Micafungin concentrations in the plasma and burn eschar of severely burned patients.

Sasaki J, Yamanouchi S, Kudo D, Endo T, Nomura R, Takuma K, Kushimoto S, Shinozawa Y, Kishino S, Hori S, Aikawa N.

Antimicrob Agents Chemother. 2012 Feb;56(2):1113-5. doi: 10.1128/AAC.05381-11. Epub 2011 Nov 14.

3.

Effect of liver and kidney function on migafungin disposition in patients with hematologic malignancies.

Nakagawa Y, Ichii Y, Saeki Y, Kodama M, Kishino S, Suzuki K.

Eur J Drug Metab Pharmacokinet. 2008 Jul-Sep;33(3):191-8.

PMID:
19007046
4.

Plasma concentration of micafungin in patients with hematologic malignancies.

Nakagawa Y, Ichii Y, Saeki Y, Kodaka M, Suzuki K, Kishino S.

J Infect Chemother. 2007 Feb;13(1):39-45. Epub 2007 Feb 26.

PMID:
17334728
5.

Ocular distribution of intravenously administered micafungin in rabbits.

Suzuki T, Uno T, Chen G, Ohashi Y.

J Infect Chemother. 2008 Jun;14(3):204-7. doi: 10.1007/s10156-008-0612-5. Epub 2008 Jun 24.

PMID:
18574655
6.

Distribution of micafungin in the tissue fluids of patients with invasive fungal infections.

Yamada N, Kumada K, Kishino S, Mochizuki N, Ohno K, Ogura S.

J Infect Chemother. 2011 Oct;17(5):731-4. doi: 10.1007/s10156-011-0240-3. Epub 2011 May 3.

PMID:
21537970
7.

Pharmacokinetics of micafungin in patients undergoing allogeneic hematopoietic stem cell transplantation.

Oshima K, Kanda Y, Kako S, Ohno K, Kishino S, Kurokawa M.

Transpl Infect Dis. 2013 Jun;15(3):323-7. doi: 10.1111/tid.12070. Epub 2013 Apr 11.

PMID:
23578224
8.

Impact of plasma exchange on pharmacokinetic disposition of micafungin.

Konishi H, Fukushima K, Saotome T, Hamamoto T, Eguchi Y, Sudo M, Sumi M, Minouchi T, Iga I, Yamaji A.

Ther Apher Dial. 2010 Jun;14(3):358-63. doi: 10.1111/j.1744-9987.2009.00797.x.

PMID:
20609192
9.

Pharmacokinetics and burn eschar penetration of intravenous ciprofloxacin in patients with major thermal injuries.

Varela JE, Cohn SM, Brown M, Ward CG, Namias N, Spalding PB.

J Antimicrob Chemother. 2000 Mar;45(3):337-42.

10.

The impact of total bilirubin on plasma micafungin levels in living-donor liver transplantation recipients with severe liver dysfunction.

Muraki Y, Iwamoto T, Kagawa Y, Sakurai H, Usui M, Isaji S, Uemoto S, Okuda M.

Biol Pharm Bull. 2009 Apr;32(4):750-4. Erratum in: Biol Pharm Bull. 2010 Jan;33(1):157.

11.

Intraocular penetration of micafungin in patient with Candida albicans endophthalmitis.

Mochizuki K, Suemori S, Udo K, Komori S, Ohkusu K, Yamada N, Ogura S.

J Ocul Pharmacol Ther. 2011 Oct;27(5):531-3. doi: 10.1089/jop.2011.0026. Epub 2011 Jul 13.

PMID:
21751880
12.

Intrapulmonary pharmacokinetics and pharmacodynamics of micafungin in adult lung transplant patients.

Walsh TJ, Goutelle S, Jelliffe RW, Golden JA, Little EA, DeVoe C, Mickiene D, Hayes M, Conte JE Jr.

Antimicrob Agents Chemother. 2010 Aug;54(8):3451-9. doi: 10.1128/AAC.01647-09. Epub 2010 May 3.

13.

Effect of blood decrease on micafungin disposition in rats.

Konishi H, Fukushima K, Sudo M, Sumi M, Minouchi T, Iga I, Shibata N, Yamaji A.

Eur J Drug Metab Pharmacokinet. 2011 Mar;36(1):35-9. doi: 10.1007/s13318-011-0023-3. Epub 2011 Feb 25.

PMID:
21350921
14.

Assessment of micafungin regimens by pharmacokinetic-pharmacodynamic analysis: a dosing strategy for Aspergillus infections.

Ikawa K, Nomura K, Morikawa N, Ikeda K, Taniwaki M.

J Antimicrob Chemother. 2009 Oct;64(4):840-4. doi: 10.1093/jac/dkp298. Epub 2009 Aug 21.

15.
16.

Reduced elimination clearance of micafungin in rats with cholestatic hyperbilirubinemia.

Konishi H, Fukushima K, Sudo M, Sumi M, Minouchi T, Iga I, Shibata N, Takada K, Yamaji A.

Fundam Clin Pharmacol. 2010 Aug;24(4):457-62. doi: 10.1111/j.1472-8206.2009.00785.x. Epub 2009 Oct 21.

PMID:
19845766
17.

Influence of fungicidal activity against Candida tropicalis on the efficacy of micafungin and liposomal amphotericin B in a neutropenic murine lethal infection model.

Takemoto K, Nakayama T, Kanazawa K, Ueda Y.

Pharmacology. 2012;90(3-4):133-45. doi: 10.1159/000341370. Epub 2012 Jul 26.

PMID:
22847175
18.

Administration of micafungin as prophylactic antifungal therapy in patients undergoing allogeneic stem cell transplantation.

Hashino S, Morita L, Takahata M, Onozawa M, Nakagawa M, Kawamura T, Fujisawa F, Kahata K, Izumiyama K, Yonezumi M, Chiba K, Kondo T, Asaka M.

Int J Hematol. 2008 Jan;87(1):91-7. doi: 10.1007/s12185-007-0011-1. Epub 2007 Dec 11.

PMID:
18224421
19.

Efficacy of micafungin in empirical therapy of deep mycosis in surgically ill patients.

Okamoto K, Katsuki T, Tamura T, Kanemitsu S, Minagawa N, Torigoe T, Shibao K, Higure A, Yamaguchi K.

J Infect Chemother. 2012 Oct;18(5):621-9. doi: 10.1007/s10156-012-0381-z. Epub 2012 Mar 27.

PMID:
22450876
20.

Clinical efficacy of micafungin for chronic pulmonary aspergillosis.

Izumikawa K, Ohtsu Y, Kawabata M, Takaya H, Miyamoto A, Sakamoto S, Kishi K, Tsuboi E, Homma S, Yoshimura K.

Med Mycol. 2007 May;45(3):273-8.

PMID:
17464848
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk